Published on 5 Mar 2024 on Simply Wall St. via Yahoo Finance
Key Insights
Institutions' substantial holdings in Coherus BioSciences implies that they have significant influence over the company's share priceA total of 14 investors have a majority stake in the company with 51% ownershipUsing data from analyst forecasts alongside ownership research, one can better assess the future performance of a company
Every investor in Coherus BioSciences, Inc. (NASDAQ:CHRS) should be aware of the most powerful shareholder groups. With 70% stake, institutions possess the maximum shares in the company. Put another way, the group faces the maximum upside potential (or downside risk).